Literature DB >> 22563932

Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.

Shun-ichi Ikeda1, Kenichi Yoshimura, Takashi Onda, Takahiro Kasamatsu, Tomoyasu Kato, Mitsuya Ishikawa, Yuko Sasajima, Hitoshi Tsuda.   

Abstract

AIM: We examined the correlations between the pretreatment values of four tumor markers (squamous cell carcinoma [SCC]-antigen, carcinoembryonic antigen [CEA], carbohydrate antigen [CA]19-9, and CA125) and postsurgical high-risk factors (parametrial involvement and positive pelvic lymph nodes) in women with SCC of the uterine cervix who had International Federation of Gynecology and Obstetrics clinical stage IB and IIA disease and underwent radical hysterectomy.
MATERIAL AND METHODS: In this retrospective study, we reviewed 291 patients between April 1989 and December 2008. The first 200 subjects, studied between 1989 and 2001, served as the training set, and another 91 subjects, studied between 2002 and 2008, comprised the test set. To evaluate the correlations between pretreatment tumor markers and postsurgical high-risk factors, the χ²-test and logistic regression analysis were used for univariate and multivariate analysis, respectively.
RESULTS: Multivariate analysis with receiver-operator curves showed that the combination of SCC-antigen, CEA, and CA19-9 strongly predicted postsurgical high-risk factors. Analysis of the training set showed that 66.7% (95% confidence interval, 52.6-84.8%) of patients who tested positive for at least two of these three tumor markers had postsurgical high-risk factors. Similar results were obtained with the test set.
CONCLUSIONS: Preoperative levels of SCC-antigen, CEA, and CA19-9 are useful for predicting the status of postsurgical high-risk factors in women with SCC of the uterine cervix who undergo radical hysterectomy.
© 2012 The Authors. Journal of Obstetrics and Gynaecology Research © 2012 Japan Society of Obstetrics and Gynecology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22563932     DOI: 10.1111/j.1447-0756.2012.01862.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  3 in total

1.  Splenic metastasis of squamous cell carcinoma of the uterine cervix: a case report and review of the literature.

Authors:  Shigeki Taga; Mari Sawada; Aya Nagai; Dan Yamamoto; Ryoji Hayase
Journal:  Case Rep Obstet Gynecol       Date:  2014-07-24

2.  High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.

Authors:  Weijing Zhang; Weiling He; Yongjie Shi; Haifeng Gu; Min Li; Zhimin Liu; Yanling Feng; Nianzhen Zheng; Chuanmiao Xie; Yanna Zhang
Journal:  PLoS One       Date:  2016-12-12       Impact factor: 3.240

3.  MicroRNA-466 with tumor markers for cervical cancer screening.

Authors:  Li-Li Zhou; Yong Shen; Jiao-Mei Gong; Ping Sun; Jia-He Sheng
Journal:  Oncotarget       Date:  2017-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.